ALIGN TECHNOLOGY, INC. Cost of Revenue
ALIGN TECHNOLOGY, INC. (ALGN) reported Cost of Revenue of $298.76 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. cost of revenue for the quarter ending 2026-06-30 was $298.76M, a 1.83% decline year-over-year.
- ALIGN TECHNOLOGY, INC. cost of revenue for the quarter ending 2026-03-31 was $303.50M, a 1.45% increase year-over-year.
- ALIGN TECHNOLOGY, INC. cost of revenue for the quarter ending 2025-12-31 was $363.97M, a 22.03% increase year-over-year.
- ALIGN TECHNOLOGY, INC. cost of revenue for the quarter ending 2025-09-30 was $356.49M, a 20.40% increase year-over-year.
- ALIGN TECHNOLOGY, INC. cost of revenue for fiscal 2025 was $1.32B, a 10.34% increase from fiscal 2024.
- ALIGN TECHNOLOGY, INC. cost of revenue for fiscal 2024 was $1.20B, a 3.85% increase from fiscal 2023.
- ALIGN TECHNOLOGY, INC. cost of revenue for fiscal 2023 was $1.16B, a 4.95% increase from fiscal 2022.
- ALIGN TECHNOLOGY, INC. cost of revenue for fiscal 2022 was $1.10B, a 8.22% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $298.76M 10-Q · filed 2026-08-05 | $602.26M 10-Q · filed 2026-08-05 | $966.24M derived: sum of 3 quarters · filed 2026-08-05 | $1.32B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $303.50M 10-Q · filed 2026-05-06 | $667.47M derived: sum of 2 quarters · filed 2026-05-06 | $1.02B derived: sum of 3 quarters · filed 2026-05-06 | $1.33B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $363.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $720.47M derived: sum of 2 quarters · filed 2026-02-27 | $1.02B derived: sum of 3 quarters · filed 2026-08-05 | $1.32B 10-K · filed 2026-02-27 |
| 2025-09-30 | $356.49M 10-Q · filed 2025-11-05 | $660.82M derived: sum of 2 quarters · filed 2026-08-05 | $959.98M 10-Q · filed 2025-11-05 | $1.26B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $304.33M 10-Q · filed 2026-08-05 | $603.49M 10-Q · filed 2026-08-05 | $901.76M derived: sum of 3 quarters · filed 2026-08-05 | $1.20B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $299.15M 10-Q · filed 2026-05-06 | $597.43M derived: sum of 2 quarters · filed 2026-05-06 | $893.53M derived: sum of 3 quarters · filed 2026-05-06 | $1.20B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $298.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $594.38M derived: sum of 2 quarters · filed 2026-02-27 | $900.24M derived: sum of 3 quarters · filed 2026-02-27 | $1.20B 10-K · filed 2026-02-27 |
| 2024-09-30 | $296.10M 10-Q · filed 2025-11-05 | $601.96M derived: sum of 2 quarters · filed 2025-11-05 | $901.58M 10-Q · filed 2025-11-05 | $1.19B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $305.86M 10-Q · filed 2025-08-06 | $605.48M 10-Q · filed 2025-08-06 | $892.68M derived: sum of 3 quarters · filed 2026-02-27 | $1.19B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $299.62M 10-Q · filed 2025-05-08 | $586.82M derived: sum of 2 quarters · filed 2026-02-27 | $883.96M derived: sum of 3 quarters · filed 2026-02-27 | $1.17B derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $287.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $584.34M derived: sum of 2 quarters · filed 2026-02-27 | $872.90M derived: sum of 3 quarters · filed 2026-02-27 | $1.16B 10-K · filed 2026-02-27 |
| 2023-09-30 | $297.14M 10-Q · filed 2024-11-05 | $585.70M derived: sum of 2 quarters · filed 2024-11-05 | $868.20M 10-Q · filed 2024-11-05 | $1.15B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $288.56M 10-Q · filed 2024-08-02 | $571.06M 10-Q · filed 2024-08-02 | $854.87M derived: sum of 3 quarters · filed 2025-02-28 | $1.13B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $282.49M 10-Q · filed 2024-05-03 | $566.31M derived: sum of 2 quarters · filed 2025-02-28 | $837.49M derived: sum of 3 quarters · filed 2025-02-28 | $1.12B derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $283.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $554.99M derived: sum of 2 quarters · filed 2025-02-28 | $836.99M derived: sum of 3 quarters · filed 2025-02-28 | $1.10B 10-K · filed 2025-02-28 |
| 2022-09-30 | $271.18M 10-Q · filed 2023-11-03 | $553.17M derived: sum of 2 quarters · filed 2023-11-03 | $817.05M 10-Q · filed 2023-11-03 | $1.10B derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $281.99M 10-Q · filed 2023-08-04 | $545.87M 10-Q · filed 2023-08-04 | $832.40M derived: sum of 3 quarters · filed 2024-02-28 | $1.09B derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $263.87M 10-Q · filed 2023-05-05 | $550.41M derived: sum of 2 quarters · filed 2024-02-28 | $811.16M derived: sum of 3 quarters · filed 2024-02-28 | $1.06B derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $286.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $547.29M derived: sum of 2 quarters · filed 2024-02-28 | $799.56M derived: sum of 3 quarters · filed 2024-02-28 | $1.02B 10-K · filed 2024-02-28 |
| 2021-09-30 | $260.75M 10-Q · filed 2022-11-04 | $513.02M derived: sum of 2 quarters · filed 2022-11-04 | $730.69M 10-Q · filed 2022-11-04 | $954.75M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $252.27M 10-Q · filed 2022-08-04 | $469.94M 10-Q · filed 2022-08-04 | $694.00M derived: sum of 3 quarters · filed 2023-02-27 | $894.06M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $217.67M 10-Q · filed 2022-05-05 | $441.73M derived: sum of 2 quarters · filed 2023-02-27 | $641.79M derived: sum of 3 quarters · filed 2023-02-27 | $769.77M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $224.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $424.11M derived: sum of 2 quarters · filed 2023-02-27 | $552.10M derived: sum of 3 quarters · filed 2023-02-27 | $708.71M 10-K · filed 2023-02-27 |
| 2020-09-30 | $200.06M 10-Q · filed 2021-11-02 | $328.04M derived: sum of 2 quarters · filed 2021-11-02 | $484.65M 10-Q · filed 2021-11-02 | $662.48M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $127.99M 10-Q · filed 2021-08-04 | $284.59M 10-Q · filed 2021-08-04 | $462.42M derived: sum of 3 quarters · filed 2022-02-25 | $632.21M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $156.61M 10-Q · filed 2021-05-05 | $334.44M derived: sum of 2 quarters · filed 2022-02-25 | $504.22M derived: sum of 3 quarters · filed 2022-02-25 | $672.63M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $177.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $347.62M derived: sum of 2 quarters · filed 2022-02-25 | $516.02M derived: sum of 3 quarters · filed 2022-02-25 | $662.90M 10-K · filed 2022-02-25 |
| 2019-09-30 | $169.79M 10-Q · filed 2020-10-30 | $338.19M derived: sum of 2 quarters · filed 2020-10-30 | $485.07M 10-Q · filed 2020-10-30 | $635.99M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $168.41M 10-Q · filed 2020-07-31 | $315.28M 10-Q · filed 2020-07-31 | $466.21M derived: sum of 3 quarters · filed 2021-02-26 | $599.72M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $146.88M 10-Q · filed 2020-05-05 | $297.80M derived: sum of 2 quarters · filed 2021-02-26 | $431.31M derived: sum of 3 quarters · filed 2021-02-26 | $555.98M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $150.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $284.43M derived: sum of 2 quarters · filed 2021-02-26 | $409.11M derived: sum of 3 quarters · filed 2021-02-26 | $518.63M 10-K · filed 2021-02-26 |
| 2018-09-30 | $133.51M 10-Q · filed 2019-10-31 | $258.19M derived: sum of 2 quarters · filed 2019-10-31 | $367.70M 10-Q · filed 2019-10-31 | $471.11M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $124.68M 10-Q · filed 2019-08-01 | $234.19M 10-Q · filed 2019-08-01 | $337.60M derived: sum of 3 quarters · filed 2020-02-28 | $430.38M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $109.52M 10-Q · filed 2019-05-02 | $212.92M derived: sum of 2 quarters · filed 2020-02-28 | $305.70M derived: sum of 3 quarters · filed 2020-02-28 | $391.27M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $103.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $196.19M derived: sum of 2 quarters · filed 2020-02-28 | $281.75M derived: sum of 3 quarters · filed 2020-02-28 | $356.47M 10-K · filed 2020-02-28 |
| 2017-09-30 | $92.78M 10-Q · filed 2018-11-01 | $178.34M derived: sum of 2 quarters · filed 2018-11-01 | $253.06M 10-Q · filed 2018-11-01 | $326.01M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $85.56M 10-Q · filed 2018-08-02 | $160.28M 10-Q · filed 2018-08-02 | $233.24M derived: sum of 3 quarters · filed 2019-02-28 | $302.62M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $74.72M 10-Q · filed 2018-05-03 | $147.67M derived: sum of 2 quarters · filed 2019-02-28 | $217.06M derived: sum of 3 quarters · filed 2019-02-28 | $281.20M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $72.95M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $142.34M derived: sum of 2 quarters · filed 2019-02-28 | $206.49M derived: sum of 3 quarters · filed 2019-02-28 | $264.58M 10-K · filed 2019-02-28 |
| 2016-09-30 | $69.39M 10-Q · filed 2017-11-02 | $133.53M derived: sum of 2 quarters · filed 2017-11-02 | $191.63M 10-Q · filed 2017-11-02 | $249.09M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $64.15M 10-Q · filed 2017-08-03 | $122.24M 10-Q · filed 2017-08-03 | $179.71M derived: sum of 3 quarters · filed 2018-02-28 | $229.76M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $58.09M 10-Q · filed 2017-05-04 | $115.56M derived: sum of 2 quarters · filed 2018-02-28 | $165.62M derived: sum of 3 quarters · filed 2018-02-28 | $216.47M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $57.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $107.53M derived: sum of 2 quarters · filed 2018-02-28 | $158.38M derived: sum of 3 quarters · filed 2018-02-28 | $205.38M 10-K · filed 2018-02-28 |
| 2015-09-30 | $50.06M 10-Q · filed 2016-11-08 | $100.91M derived: sum of 2 quarters · filed 2016-11-08 | $147.91M 10-Q · filed 2016-11-08 | $195.85M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $50.85M 10-Q · filed 2016-08-04 | $97.85M 10-Q · filed 2016-08-04 | $145.79M derived: sum of 3 quarters · filed 2017-02-28 | $190.61M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $47.00M 10-Q · filed 2016-05-05 | $94.93M derived: sum of 2 quarters · filed 2017-02-28 | $139.76M derived: sum of 3 quarters · filed 2017-02-28 | $186.81M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $47.94M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $92.76M derived: sum of 2 quarters · filed 2017-02-28 | $139.81M derived: sum of 3 quarters · filed 2017-02-28 | $183.21M 10-K · filed 2017-02-28 |
| 2014-09-30 | $44.82M 10-Q · filed 2015-10-29 | $91.88M derived: sum of 2 quarters · filed 2015-10-29 | $135.27M 10-Q · filed 2015-10-29 | $177.09M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $47.05M 10-Q · filed 2015-07-30 | $90.45M 10-Q · filed 2015-07-30 | $132.27M derived: sum of 3 quarters · filed 2016-02-25 | $171.68M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $43.40M 10-Q · filed 2015-05-01 | $85.21M derived: sum of 2 quarters · filed 2016-02-25 | $124.63M derived: sum of 3 quarters · filed 2016-02-25 | $164.76M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $41.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $81.23M derived: sum of 2 quarters · filed 2016-02-25 | $121.37M derived: sum of 3 quarters · filed 2016-02-25 | $162.10M 10-K · filed 2016-02-25 |
| 2013-09-30 | $39.42M 10-Q · filed 2014-10-30 | $79.55M derived: sum of 2 quarters · filed 2014-10-30 | $120.28M 10-Q · filed 2014-10-30 | $156.65M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $40.14M 10-Q · filed 2014-07-31 | $80.87M 10-Q · filed 2014-07-31 | $117.23M derived: sum of 3 quarters · filed 2015-02-26 | $153.38M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $40.73M 10-Q · filed 2014-05-01 | $77.09M derived: sum of 2 quarters · filed 2015-02-26 | $113.24M derived: sum of 3 quarters · filed 2015-02-26 | $150.06M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $36.36M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $72.51M derived: sum of 2 quarters · filed 2015-02-26 | $109.33M derived: sum of 3 quarters · filed 2015-02-26 | $143.65M 10-K · filed 2015-02-26 |
| 2012-09-30 | $36.15M 10-Q · filed 2013-11-01 | $72.97M derived: sum of 2 quarters · filed 2013-11-01 | $107.29M 10-Q · filed 2013-11-01 | $140.65M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $36.83M 10-Q · filed 2013-08-02 | $71.14M 10-Q · filed 2013-08-02 | $104.50M derived: sum of 3 quarters · filed 2014-02-28 | $138.02M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $34.32M 10-Q · filed 2013-05-03 | $67.67M derived: sum of 2 quarters · filed 2014-02-28 | $101.20M derived: sum of 3 quarters · filed 2014-02-28 | $130.15M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $33.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $66.88M derived: sum of 2 quarters · filed 2014-02-28 | $95.83M derived: sum of 3 quarters · filed 2014-02-28 | $118.46M 10-K · filed 2014-02-28 |
| 2011-09-30 | $33.52M 10-Q · filed 2012-11-09 | $62.47M derived: sum of 2 quarters · filed 2012-11-09 | $85.10M 10-Q · filed 2012-11-09 | $106.24M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $28.95M 10-Q · filed 2012-08-02 | $51.58M 10-Q · filed 2012-08-02 | $72.72M derived: sum of 3 quarters · filed 2013-03-01 | $93.73M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $22.63M 10-Q · filed 2012-05-08 | $43.77M derived: sum of 2 quarters · filed 2013-03-01 | $64.78M derived: sum of 3 quarters · filed 2013-03-01 | $85.96M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $21.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $42.15M derived: sum of 2 quarters · filed 2013-03-01 | $63.33M derived: sum of 3 quarters · filed 2013-03-01 | $83.71M 10-K · filed 2013-03-01 |
| 2010-09-30 | $21.01M 10-Q · filed 2011-11-04 | $42.19M derived: sum of 2 quarters · filed 2011-11-04 | $62.57M 10-Q · filed 2011-11-04 | $85.38M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $21.18M 10-Q · filed 2011-08-08 | $41.56M 10-Q · filed 2011-08-08 | $64.37M derived: sum of 3 quarters · filed 2012-02-29 | $84.64M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $20.38M 10-Q · filed 2011-05-05 | $43.19M derived: sum of 2 quarters · filed 2012-02-29 | $63.46M derived: sum of 3 quarters · filed 2012-02-29 | $81.80M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | $22.81M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $43.08M derived: sum of 2 quarters · filed 2012-02-29 | $61.42M derived: sum of 3 quarters · filed 2012-02-29 | $78.84M 10-K · filed 2012-02-29 |
| 2009-09-30 | $20.27M 10-Q · filed 2010-11-04 | $38.61M derived: sum of 2 quarters · filed 2010-11-04 | $56.03M 10-Q · filed 2010-11-04 | |
| 2009-06-30 | $18.34M 10-Q · filed 2010-08-05 | $35.76M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | $78.85M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |